-+ 0.00%
-+ 0.00%
-+ 0.00%
Patients In Aethlon Medical's Second Cohort Of Its Australian Oncology Feasibility Study Demonstrated Biological Changes
Share
Listen to the news

Second cohort findings consistent with previously reported observations; independent statistical analysis planned following completion of all three patient cohorts

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending